News Detail
New Delhi, 25 Dec 2024: AbbVie Healthcare India which has been in the dock for unethical marketing practices today rejected the allegations of wrongdoing by the Department of Pharmaceuticals (DoP).
Calling the DoP’s action “without merit” it said that......
View Details
Source : Economic Times
AbbVie Healthcare India
Department of Pharmaceuticals
unethical marketing practices
Allergan Aesthetics
healthcare professionals
Related News
- Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)
- SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)
- 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)
- Three arrested with 900 cough syrup Bottles worth Rs 2 lakh (15-01-2025)